IP Library Granted Patent US 12,419,730
Granted Patent B2
US 12,419,730 · App. 17/929,081 · Granted Sep 23, 2025

Dental medicament applicator

Inventors: Tyler Ferris (Boerne, TX); Jeff Reeh (Boerne, TX)
Assignee: Cav-Aid LLC
A61C19/063A61K8/21A61Q11/00A61K2800/87A61K2800/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,730
App. No.
17/929,081
Granted
Sep 23, 2025
Kind
B2
Abstract

A dental medicament applicator is disclosed. In one embodiment, a placement device is sized for insertion at a dental site, such as an interproximal site. The placement device includes a central body and at least one active matrix secured to the central body containing a topical substance, such as a fluoride-containing chemical agent, silver diamine fluoride, or a peptide-based chemical agent, for example. One or two wings extend from the central body to provide subterminal opposition surfaces to hold the placement device during placement. The one or more wings are free of the topical substance. The active matrix, in response to being physically affixed to the dental site, delivers the topical substance at a controlled rate to the dental site while the placement device dissolves at a quicker controlled rate.

Claims (47)

1. A dental medicament applicator comprising:

a placement device sized for insertion at a dental site, the dental site including an interproximal site with a dental caries, the placement device comprised of hydroxypropyl methyl cellulose (HPMC) polymers, the placement device including a central body, a first wing, and a second wing;

the first wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the first wing therebetween, the first wing being sized to bend around the interproximal site so that, when bent, the first wing engages a dental surface adjacent the dental site and stabilizes the central body over the dental caries, the first wing being free of a topical substance for treating incipient lesions;

the second wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the second wing therebetween, the second wing being sized to bend around the interproximal site so that, when bent, the second wing engages a dental surface adjacent the dental site and stabilizes the central body over the dental caries, the second wing being free of the topical substance;

at least one active matrix secured to the front of the central body, the at least one active matrix comprised of pullulan polymers containing the topical substance;

each of the first wing and the second wing having a larger surface area than the at least one active matrix;

the placement device, in response to being physically affixed to the dental site and bent around the interproximal site and the adjacent dental surfaces, dissolving at a first controlled rate; and

the at least one active matrix, in response to the central body being physically affixed over the dental caries, transitioning to a gelatinous state while delivering the topical substance to the dental caries at a second controlled rate that is slower than the first controlled rate, the gelatinous active matrix thereafter dissolving and being bio-reabsorbed,

whereby the dental medicament applicator completely dissolves following dissolution of the placement device at the first controlled rate and delivery of the topical substance at the second controlled rate.

2. The dental medicament applicator as recited in claim 1 , wherein the central body and the first wing are at least partially integrated.

3. The dental medicament applicator as recited in claim 1 , wherein the central body and the first wing are integral.

4. The dental medicament applicator as recited in claim 1 , wherein the central body and the second wing are at least partially integrated.

5. The dental medicament applicator as recited in claim 1 , wherein the central body and the second wing are integral.

6. The dental medicament applicator as recited in claim 1 , wherein the central body and the at least one active matrix are at least partially integrated.

7. The dental medicament applicator as recited in claim 1 , wherein the central body and the at least one active matrix are integral.

8. The dental medicament applicator as recited in claim 1 , wherein the first wing further comprises a proximal viewing area interposed between the central body and the subterminal opposition surfaces.

9. The dental medicament applicator as recited in claim 1 , wherein the second wing further comprises a proximal viewing area interposed between the central body and the subterminal opposition surfaces.

10. The dental medicament applicator as recited in claim 1 , wherein each of the first and second wings have a first transparency and the at least one active matrix has a second transparency, the first transparency being visually different than the second transparency.

11. The dental medicament applicator as recited in claim 1 , wherein each of the first and second wings have a first transparency and the at least one active matrix has a second transparency, the first transparency being more transparent than the second transparency.

12. The dental medicament applicator as recited in claim 1 , wherein each of the first and second wings comprise a shape selected from the group consisting of single lobes, double lobes, polygon forms, and rectangular forms.

13. The dental medicament applicator as recited in claim 1 , wherein the placement device further comprises a material selected from the group consisting of biodegradable materials, bioresorbable materials, and resorbable materials.

14. The dental medicament applicator as recited in claim 1 , wherein the at least one matrix further comprises a material selected from the group consisting of biodegradable materials, bioresorbable materials, and resorbable materials.

15. The dental medicament applicator as recited in claim 1 , wherein the topical substance further comprises at least one of a fluoride-containing chemical agent and a calcium-containing chemical agent.

16. The dental medicament applicator as recited in claim 1 , wherein the topical substance further comprises silver diamine fluoride.

17. The dental medicament applicator as recited in claim 1 , wherein the topical substance further comprises a peptide-based chemical agent.

18. The dental medicament applicator as recited in claim 1 , wherein the topical substance further comprises a peptide-based chemical agent, the peptide-based chemical agent including a combination of amelogenin, a fluoride-containing chemical agent, a calcium-containing chemical agent, and a phosphate-containing chemical agent.

19. A dental medicament applicator comprising:

a placement device sized for insertion at a dental site, the dental site including an interproximal site with a dental caries, the placement device comprised of hydroxypropyl methyl cellulose (HPMC) polymers, the placement device including a central body, a first wing, and a second wing;

the first wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the first wing therebetween, the first wing being sized to bend around the interproximal site so that, when bent, the first wing engages a dental surface adjacent the dental site and stabilizes the central body over the dental caries, the first wing being free of a topical substance for treating incipient lesions;

the second wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the second wing therebetween, the second wing being sized to bend around the interproximal site so that, when bent, the second wing engages a dental surface adjacent the dental site and stabilizes the central body over the dental caries, the second wing being free of the topical substance;

at least one active matrix secured to the front of the central body, the at least one active matrix comprised of pullulan polymers containing the topical substance;

each of the first wing and the second wing having a larger surface area than the at least one active matrix;

the placement device, in response to being physically affixed to the dental site and bent around the interproximal site and the adjacent dental surfaces, dissolving at a first controlled rate within about 20 seconds to about 60 seconds; and

the at least one active matrix, in response to the central body being physically affixed over the dental caries, transitioning to a gelatinous state while delivering the topical substance to the dental caries at a second controlled rate within about 30 minutes to about 90 minutes, the gelatinous active matrix thereafter dissolving and being bio-reabsorbed,

whereby the dental medicament applicator completely dissolves following dissolution of the placement device at the first controlled rate and delivery of the topical substance at the second controlled rate.

20. A dental medicament applicator comprising:

a placement device sized for insertion at a dental site, the dental site including an interproximal site with a dental caries, the placement device comprised of water-soluble polysaccharide polymers, the placement device including a central body, a first wing, and a second wing;

the first wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the first wing therebetween, the first wing being sized to bend around the interproximal site so that, when bent, the first wing engages a dental surface adjacent the dental site and stabilizes the central body over the dental caries, the first wing being free of a topical substance for treating incipient lesions;

the second wing providing subterminal opposition surfaces in which palmar surfaces of a thumb and an index finger can hold the second wing therebetween, the second wing being sized to bend around the interproximal site so that, when bent, the second wing engages a dental surface adjacent the dental site and stabilizes the central body over the dental caries, the second wing being free of a topical substance for treating incipient lesions;

at least one active matrix secured to the front of the central body, the at least one active matrix comprised of water-soluble polysaccharide polymers containing the topical substance;

the placement device, in response to being physically affixed to the dental site and bent around the interproximal site and the adjacent dental surfaces, dissolving at a first controlled rate; and

the at least one active matrix, in response to the central body being physically affixed over the dental caries, transitioning to a gelatinous state while delivering the topical substance to the dental caries at a second controlled rate that is slower than the first controlled rate, the gelatinous active matrix thereafter dissolving and being bio-reabsorbed,

whereby the dental medicament applicator completely dissolves following dissolution of the placement device at the first controlled rate and delivery of the topical substance at the second controlled rate.

21. The dental medicament applicator of claim 20 , wherein the dental surface adjacent the dental site is a mesial or distal surface of the same tooth that contains the dental caries, the first wing and the second wing being configured, when bent, to engage that mesial or distal surface to stabilize the central body.

22. The dental medicament applicator of claim 20 , wherein the dental surface adjacent the dental site is a mesial or distal surface of a tooth immediately adjacent to the tooth that contains the dental caries, the first wing and the second wing being configured, when bent, to engage that adjacent-tooth surface to stabilize the central body.

23. The dental medicament applicator of claim 1 , wherein the dental surface adjacent the dental site is a mesial or distal surface of the same tooth that contains the dental caries, the first wing and the second wing being configured, when bent, to engage that mesial or distal surface to stabilize the central body.

24. The dental medicament applicator of claim 1 , wherein the dental surface adjacent the dental site is a mesial or distal surface of a tooth immediately adjacent to the tooth that contains the dental caries, the first wing and the second wing being configured, when bent, to engage that adjacent-tooth surface to stabilize the central body.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2022
From: FERRIS, TYLER; REEH, JEFF
To: CAV-AID LLC
Reel/Frame 060965/0697 →
Continuity (3)
Continuation In Part 17668840 · Feb 10, 2022
Provisional Application 63147751 · Feb 10, 2021
Related Publication 20230000603A1 · Jan 5, 2023
References Cited (53)
US 3679360A · Rubin et al. · 1972 [cited by applicant]
US 4226848A · Nagai et al. · 1980 [cited by applicant]
US 4568535A · Loesche · 1986 [cited by applicant]
US 4837007A · Duckworth et al. · 1989 [cited by applicant]
US 5049077A · Goldin · 1991 [cited by applicant]
US 5087200A · Brajnovic et al. · 1992 [cited by applicant]
US 5154612A · Carlsson et al. · 1992 [cited by applicant]
US 6287120B1 · Wiesel · 2001 [cited by examiner]
US 6565960B2 · Koob et al. · 2003 [cited by applicant]
US 6827575B1 · Jorneus · 2004 [cited by applicant]
US 7056118B2 · Allred et al. · 2006 [cited by applicant]
US 7118376B2 · Jodaikin et al. · 2006 [cited by applicant]
US D549829S · Jodaikin et al. · 2007 [cited by applicant]
US D553245S · Jodaikin et al. · 2007 [cited by applicant]
US 7491058B2 · Jorneus et al. · 2009 [cited by applicant]
US D605773S · Jodaikin et al. · 2009 [cited by applicant]
US 7797912B2 · Hammond et al. · 2010 [cited by applicant]
US 7850453B2 · Jodaikin et al. · 2010 [cited by applicant]
US 7883336B2 · Hansson · 2011 [cited by applicant]
US 8287277B2 · Jodaikin et al. · 2012 [cited by applicant]
US 9668844B2 · Jodaikin et al. · 2017 [cited by applicant]
US 10849729B2 · Sagel et al. · 2020 [cited by applicant]
US 10960192B2 · Masri et al. · 2021 [cited by applicant]
US 11439489B2 · Ferris et al. · 2022 [cited by applicant]
US 20050048102A1 · Tapolsky et al. · 2005 [cited by applicant]
US 20050175959A1 · Jodaikin · 2005 [cited by examiner]
US 20050196727A1 · Jessop · 2005 [cited by applicant]
US 20050239015A1 · Dragan · 2005 [cited by applicant]
US 20100203467A1 · Karazivan · 2010 [cited by applicant]
US 20110200972A1 · Mythen · 2011 [cited by applicant]
US 20140186427A1 · Breitenbach et al. · 2014 [cited by applicant]
US 20150125810A1 · Jodaikin · 2015 [cited by examiner]
US 20150290122A1 · Boe · 2015 [cited by applicant]
US 20210000579A1 · Higdon · 2021 [cited by applicant]
US 20210030668A1 · Schmitz et al. · 2021 [cited by applicant]
US 20210186672A1 · Wandera · 2021 [cited by examiner]
US 20220249217A1 · Ferris et al. · 2022 [cited by applicant]
DE 202009009789 · 2009 [cited by applicant]
EP 1263347 · 2007 [cited by applicant]
WO 1998016503 · 1998 [cited by applicant]
WO 2017182425 · 2017 [cited by applicant]
SmileCare (A subscription-based discount health care plan) [online]. [retrieved Oct. 19, 2023]. Retrieved from the Internet: https://www.smilecareplymouth.co.uk/blog/what-is-the-average-length-of-the-teeth-importance-in… [cited by examiner]
Hal Open Science (a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents)[ online]. [retrieved Mar. 28, 2024]. Retrieved from the Internet: https://inria.hal.science/… [cited by examiner]
Shutz Dental Micerium Group, Impla Interim Implant, Impla temp.implant, 3,3/11,5mm, 10pcs, The Interim Implant, for securely fixing drilling templates and temporary bridges, date accessed Jul. 7, 2011, 1 page, Rosbach, … [cited by applicant]
WIPO International Search Report and Written Opinion of the International Searching Authority for PCT/US2022/016006 dated May 6, 2022. [cited by applicant]
Chong et al., “Slow-release fluoride devices for the control of dental decay (Review).” Cochrane Database of Systematic Reviews 2018, Issue 3, Art. No. CD005101 (Year: 2018). [cited by applicant]
Tommasina Coviello et al., “Polysaccharide hydrogels for modified release formulations (Review).” University “La Sapienza”, Faculty of Pharmacy, P.le Aldo Moro 5, 00185 Rome, Italy. ScienceDirect Journal of Controlled R… [cited by applicant]
Ana Filipa Borges et al., “Oral films: current status and future perspectives. Galenical development and quality attributes.” Bluepharma, Indústria Farmacêutica, S.A.Faculty of Pharmacy, University of Coimbra CIEPQPF—Fa… [cited by applicant]
M A Shadab Siddiqui et al., “Bioinspired composite structures: A comprehensive review of natural materials, fabrication methods, and engineering applications.” Department of Mechanical Engineering, Chittagong University… [cited by applicant]
Jianjun Yan et al., “Preparation and Properties of Pullulan Composite Films.” School of Textiles, Tianjin Polytechnic University, Tianjin, 300387, China. Advanced Materials Research vols. 476-478 (2012) pp. 2100-2104, O… [cited by applicant]
Daniela Pasqui et al., “Polysaccharide-Based Hydrogels: The Key Role of Water in Affecting Mechanical Properties.” Interuniversity Research Centre for Advanced Medical Systems (C.R.I.S.M.A.), Viale Matteotti 15, Colle d… [cited by applicant]
Emma Adriana Ozon et al., “Three-Dimensional Printing Technologies in Oral Films Manufacturing—A Minireview.” Faculty of Pharmacy, Department of Pharmaceutical Technology and Biopharmacy, “Carol Davila” University of Me… [cited by applicant]
Extended European Search Report (EESR) for EP 23194463.8-1122 dated Jan. 18, 2024. [cited by applicant]